Open access
Jul 2026
Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe
Many essential medicines in Zimbabwe have actionable pharmacogenomic biomarkers, but gaps in local genomic guidance remain, and strengthening local evidence generation and PGx implementation is essential.
T. Mazhindu, Z. Chikwambi, Kevin V. Grimes et al.
· Frontiers in Pharmacology · 0 citations